XML 14 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Revenue $ 130,638 $ 84,758 $ 364,775 $ 230,066
Cost of revenue 72,395 45,527 199,782 123,895
Gross profit 58,243 39,231 164,993 106,171
Operating expenses:        
Research and development 13,359 10,232 39,509 29,316
Sales and marketing 13,592 9,001 38,168 27,073
General and administrative 30,354 18,134 85,481 51,070
Total operating expenses 57,305 37,367 163,158 107,459
Operating income (loss) 938 1,864 1,835 (1,288)
Other expense, net (7,567) (4,206) (20,768) (8,980)
Loss before income taxes (6,629) (2,342) (18,933) (10,268)
Income tax provision (315) (10) (255) (13,783)
Net loss $ (6,944) $ (2,352) $ (19,188) $ (24,051)
Net loss per share, basic (in usd per share) $ (0.28) $ (0.10) $ (0.77) $ (1.01)
Net loss per share, diluted (in usd per share) $ (0.28) $ (0.10) $ (0.77) $ (1.01)
Weighted average number of common shares outstanding, basic (in shares) 25,114,762 24,175,762 25,075,941 23,905,322
Weighted average number of common shares outstanding, diluted (in shares) 25,114,762 24,175,762 25,075,941 23,905,322